Exolvo Biosciences

Revolutionizing oral delivery of biologic therapies

What is the Challenge?

Biologic therapies, essential for treating various chronic and complex diseases, are predominantly administered through injections. This method poses challenges such as patient discomfort, reduced adherence, and increased healthcare costs. Despite their efficacy, the invasive nature of injections limits the full potential of biologics, underscoring a significant need for more patient-friendly delivery methods.

What is the Solution?

Exolvo Biosciences is at the forefront of transforming biologic drug delivery with its innovative ‘smart capsule’ technology. Developed through extensive research within Verily (Google) Life Sciences and originating from the Google X ‘moonshot’ program, these capsules utilize dissolvable microneedles to facilitate the oral administration of large, complex molecules. This approach not only enhances patient comfort by eliminating the need for injections but also ensures the effective delivery of biologics, maintaining their therapeutic efficacy.

By enabling oral delivery, Exolvo’s technology aims to improve patient adherence, reduce healthcare costs associated with injectable therapies, and broaden the accessibility of biologic treatments. The flexibility and modularity of the smart capsules allow for their application across a diverse range of biologic drugs, positioning Exolvo as a leader in the next generation of drug delivery systems.

Latest